AstraZeneca

AstraZeneca is a global biopharmaceutical company based in Cambridge, UK, established in 1999 from the merger of Astra AB and Zeneca Group. The company specializes in the research, development, and commercialization of prescription medicines across various therapeutic areas, including oncology, cardiovascular health, renal and metabolism, respiratory and immunology, vaccines, and rare diseases.

AstraZeneca offers a diverse product portfolio that includes biologics, prescription pharmaceuticals, and vaccines. Its products are marketed worldwide through local marketing companies, distributors, and representative offices, catering to both primary care and specialty care physicians. The company has expanded its capabilities through significant acquisitions, enhancing its focus on biotechnology and rare diseases. AstraZeneca actively collaborates with academic institutions, governments, and other companies to foster innovation and improve product distribution, and it is involved in over 5,600 clinical trials globally, reflecting its commitment to advancing medical research.